ProCE Banner Activity

CME

Achieving the Potential of ART: Upping Our Game in HIV Treatment

Video

On-demand webcast of an expert faculty presentation and case discussion on best practices in using antiretroviral therapy (ART) to treat people living with HIV.

European Learners: 0.50 hours EBAC® effective education time

Physicians: maximum of 0.50 AMA PRA Category 1 Credit

Released: December 11, 2024

Expiration: December 10, 2025

Share

Faculty

Dinah Bons

Dinah Bons

Founder and Director, Trans Clinic Amsterdam
Co-Chair, Trans United Europe BPOC Trans Network Amsterdam
Co-Chair, Trans Europe (TGEU) Berlin
Member, H-Team Amsterdam
Member, HIV Outcomes
Amsterdam, Netherlands

Yvonne Gilleece

Yvonne Gilleece, MB, BCh, BAO, FRCP

Honorary Clinical Professor and Consultant in HIV Medicine & Sexual Health
Brighton & Sussex Medical School and University Hospitals Sussex NHS Foundation Trust
Chair of the British HIV Association
Lead for HIV & Women
Lead for HIV & Hepatitis
Brighton, United Kingdom

Justyna Kowalska

Justyna Kowalska, MD, PhD

Department of Adults’ Infectious Diseases
Medical University of Warsaw
Warsaw, Poland

Angelina Namiba

Angelina Namiba

Patient Advocate/Project Manager
4M Network of Mentor Mothers Living With HIV
London, United Kingdom

Jürgen Rockstroh

Jürgen Rockstroh, MD

Professor of Medicine
Head of Infectious Diseases
Department of Medicine I
University Hospital Bonn
Bonn, Germany

Sophie Strachan

Sophie Strachan

CEO, Sophia Forum
Sexual Health Advisor, Chelsea & Westminster Hospital
Gender and Health Equity Advocate
London, United Kingdom

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Gilead Sciences, Inc.

Gilead Sciences, Inc.

Target Audience

This activity is intended for European healthcare professionals who treat, care for, and/or support people living with HIV and individuals who need or want PrEP.

Program Learning Goal

The goal of this activity is to inspire European healthcare professionals to recognize aspects of their provision of HIV prevention and treatment where they can implement improvements that will enhance PrEP uptake and ensure that each person receives an individualized regimen that fits well into their life

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Work in partnership with people living with HIV to devise evidence-based and individualized antiretroviral treatment strategies that maximize clinical outcomes and quality of life and minimize adverse outcomes such as those associated with drug resistance

  • Devise care strategies that integrate insights from the latest data on emerging PrEP options and studies of long-term ART safety and efficacy

Disclosure

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Primary Author

Dinah Bons,

Founder and Director, Trans Clinic Amsterdam
Co-Chair, Trans United Europe BPOC Trans Network Amsterdam
Co-Chair, Trans Europe (TGEU) Berlin
Member, H-Team Amsterdam
Member, HIV Outcomes
Amsterdam, Netherlands

Dinah Bons has no relevant financial relationships to disclose.

Yvonne Gilleece, MB, BCh, BAO, FRCP

Honorary Clinical Professor and Consultant in HIV Medicine & Sexual Health
Brighton & Sussex Medical School and University Hospitals Sussex NHS Foundation Trust
Chair of the British HIV Association
Lead for HIV & Women
Lead for HIV & Hepatitis
Brighton, United Kingdom

Yvonne Gilleece, MB, BCh, BAO, FRCP: consultant/advisor/speaker: Gilead, ViiV.

Justyna Kowalska, MD, PhD

Department of Adults’ Infectious Diseases
Medical University of Warsaw
Warsaw, Poland

Justyna Kowalska, MD, PhD: consultant/advisor/speaker: Gilead, GlaxoSmithKline, Janssen, Merck Sharp & Dohme, ViiV.

Angelina Namiba,

Patient Advocate/Project Manager
4M Network of Mentor Mothers Living With HIV
London, United Kingdom

Angelina Namiba has no relevant financial relationships to disclose.

Jürgen Rockstroh, MD

Professor of Medicine
Head of Infectious Diseases
Department of Medicine I
University Hospital Bonn
Bonn, Germany

Jürgen Rockstroh, MD: consultant/advisor/speaker: AbbVie, Gilead, Janssen, Merck Sharp & Dohme, ViiV.

Sophie Strachan,

CEO, Sophia Forum
Sexual Health Advisor, Chelsea & Westminster Hospital
Gender and Health Equity Advocate
London, United Kingdom

Sophie Strachan: researcher: Gilead, Merck Sharp & Dohme.

The planners and content peer reviewers from Clinical Care Options, LLC do not have any relevant financial relationships to disclose.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 0.5 hour. To successfully complete this activity and receive credit, participants must follow these steps during the period from December 11, 2024, through December 10, 2025:

  1. Login or Sign Up for an account by clicking at the top of this page.
  2. Read the target audience, learning objectives, and faculty disclosures.
  3. View and study the content in its entirety.
  4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65 and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page. There are no costs/fees for this activity.

Format

This program has been made available online.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

EBAC® Accreditation 

A blue heart and yellow starsDescription automatically generated

This program is accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC®) for 0.5 hours of effective education time. 

EBAC® holds an agreement on mutual recognition of substantive equivalency with the US Accreditation Council for CME (ACCME) and the Royal College of Physicians and Surgeons of Canada, respectively. 

Through an agreement between the European Board for Accreditation of Continuing Education for Health Professionals (EBAC®) and the American Medical Association, physicians may convert EBAC® External CME credits to AMA PRA Category 1 Credits™. Information on the process to convert EBAC® credit to AMA credit can be found on the AMA website. Other health care professionals may obtain from the AMA a certificate of having participated in an activity eligible for conversion of credit to AMA PRA Category 1 Credit™. 

EBAC® is a member of the International Academy for CPD Accreditation (IACPDA) and a partner member of the International Association of Medical Regulatory Authorities (IAMRA).

CME Passport

A logo for a companyDescription automatically generated

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit www.cmepassport.org to create your account.